United Therapeutics Corporation (UTHR)

United Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	14,066	10,333	12,674	9,731	6,746	3,865
Market Cap Growth	4.25%	-18.47%	30.24%	44.26%	74.53%	-18.57%
Enterprise Value	11,959	8,039	10,636	8,601	5,711	3,229
PE Ratio	15.01	10.49	17.43	20.45	13.10	-36.99
PS Ratio	5.63	4.44	6.55	5.77	4.55	2.67
PB Ratio	2.64	1.73	2.64	2.46	1.99	1.39
P/FCF Ratio	18.70	13.82	19.10	20.38	9.65	-13.31
P/OCF Ratio	14.36	10.57	15.79	16.27	8.93	-18.71
EV/Sales Ratio	4.79	3.45	5.49	5.10	3.85	2.23
EV/EBITDA Ratio	8.00	5.80	10.28	12.98	8.02	-43.11
EV/EBIT Ratio	8.31	6.03	10.82	14.04	8.62	-26.73
EV/FCF Ratio	15.89	10.75	16.03	18.02	8.17	-11.12
Debt / Equity Ratio	0.11	0.12	0.17	0.20	0.24	0.31
Debt / EBITDA Ratio	0.40	0.50	0.77	1.21	1.12	-11.35
Debt / FCF Ratio	0.80	0.94	1.21	1.68	1.14	-2.93
Quick Ratio	3.50	4.07	8.91	6.97	6.16	3.54
Current Ratio	3.78	4.41	9.85	7.61	6.70	4.03
Asset Turnover	0.37	0.34	0.34	0.34	0.34	0.37
Interest Coverage	24.49	22.49	30.34	32.93	28.19	-2.73
Return on Equity (ROE)	18.70%	17.70%	16.30%	12.80%	16.20%	-4.00%
Return on Assets (ROA)	15.40%	14.50%	12.80%	9.70%	11.90%	-2.70%
Return on Capital (ROIC)	16.10%	13.70%	13.39%	9.36%	11.40%	-5.17%
Earnings Yield	7.47%	9.53%	5.74%	4.89%	7.63%	-2.70%
FCF Yield	5.35%	7.23%	5.24%	4.91%	10.36%	-7.51%
Buyback Yield / Dilution	-0.20%	-2.47%	-2.54%	-6.05%	-1.83%	0.45%
Total Shareholder Return	-0.20%	-2.47%	-2.54%	-6.05%	-1.83%	0.45%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).